Conjoint Senior Lecturer

Dr Kate Patterson

medicine-health
St Vincent's Clinical School

Publications

  • Book Chapters | 2009
    Dr Kate Patterson
    Bennett HL; Brummer T; Timpson P; Patterson K; Daly RJ, 2009, 'Signalling by the EGF receptor in human cancers: Accentuate the positive, eliminate the negative.', in Haley JD; Gullick WJ (ed.), Cancer Drug Discovery and Development: EGFR Signaling Networks in Cancer Therapy, edn. Original, Humana Press, pp. 224 - 244, http://www.springerlink.com/content/un6881170p36l852/
  • Journal articles | 2019
    Dr Kate Patterson
    Dorfman BS; Terrill B; Patterson K; Yarden A; Blonder R, 2019, 'Teachers personalize videos and animations of biochemical processes: results from a professional development workshop', Chemistry Education Research and Practice, vol. 20, pp. 772 - 786, http://dx.doi.org/10.1039/c9rp00057g
    Journal articles | 2018
    Dr Kate Patterson
    Burnett DL; Langley DB; Schofield P; Hermes JR; Chan TD; Jackson J; Bourne K; Reed JH; Patterson K; Porebski BT; Brink R; Christ D; Goodnow CC, 2018, 'Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination', Science, vol. 360, pp. 223 - 226, http://dx.doi.org/10.1126/science.aao3859
    Journal articles | 2013
    Dr Kate Patterson
    Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ, 2013, 'Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer', Oncogene, vol. 32, pp. 2891 - 2899, http://dx.doi.org/10.1038/onc.2012.300
    Journal articles | 2012
    Dr Kate Patterson
    Valdes-Mora F; Song JZ; Statham AL; Strbenac D; Robinson MD; Nair SS; Patterson K; Tremethick DJ; Stirzaker C; Clark SJ, 2012, 'Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer', Genome Research, vol. 22, pp. 307 - 321, http://dx.doi.org/10.1101/gr.118919.110
    Journal articles | 2012
    Dr Kate Patterson
    Gloss B; Patterson K; Barton CA; Gonzalez M; Scurry JP; Hacker NF; Sutherland RL; O''brien P; Clark SJ, 2012, 'Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers', Cancer Letters, vol. 318, pp. 76 - 85, http://dx.doi.org/10.1016/j.canlet.2011.12.003
    Journal articles | 2011
    Dr Kate Patterson
    Patterson K; Molloy L; Qu W; Clark SJ, 2011, 'DNA methylation: Bisulphite modification and analysis', Journal of Visualized Experiments, pp. e3170, http://dx.doi.org/10.3791/3170
    Journal articles | 2011
    Dr Kate Patterson
    Patterson K; Molloy L; Qu W; Clark S, 2011, 'DNA methylation: Bisulphite modification and analysis', Journal of Visualized Experiments, http://dx.doi.org/10.3791/3170
    Journal articles | 2011
    Dr Kate Patterson
    Wang L; Chen H; Liu F; Madigan MC; Power C; Hao J; Patterson K; Pourgholami MH; O Brien P; Perkins A; Li Y, 2011, 'Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer', Cancer Letters, vol. 300, pp. 122 - 133, http://dx.doi.org/10.1016/j.canlet.2010.09.013
    Journal articles | 2011
    Dr Kate Patterson
    Devaney J; Stirzaker C; Qu W; Song JZ; Statham AL; Patterson K; Horvath LG; Tabor B; Coolen MW; Hulf T; Kench JG; Henshall SM; Pe benito R; Haynes AM; Mayor R; Peinado M; Sutherland RL; Clark SJ, 2011, 'Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers', Cancer Epidemiology Biomarkers and Prevention, vol. 20, pp. 148 - 159, http://dx.doi.org/10.1158/1055-9965.EPI-10-0719
    Journal articles | 2011
    Dr Kate Patterson
    Patterson K; Molloy L; Qu W; Clark S, 2011, 'DNA methylation: bisulphite modification and analysis.', Journal of visualized experiments : JoVE
    Journal articles | 2010
    Dr Kate Patterson
    Patterson K; Brummer T; Daly RJ; O Brien P, 2010, 'DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs', Biochimica et Biophysica ACTA, vol. 1803, pp. 1003 - 1012, http://dx.doi.org/10.1016/j.bbamcr.2010.03.014
    Journal articles | 2009
    Dr Kate Patterson
    Patterson K; Brummer T; O Brien P; Daly RJ, 2009, 'Dual-specificity phosphatases: Critical regulators with diverse cellular targets', Biochemical Journal, vol. 418, pp. 475 - 489, http://dx.doi.org/10.1042/BJ20082234
    Journal articles | 2009
    Dr Kate Patterson
    Knibb J; Woollams A; Hodges JR; Patterson K, 2009, 'Making sense of progressive non-fluent aphasia: An analysis of conversational speech', Brain, vol. 132, pp. 2734 - 2746, http://dx.doi.org/10.1093/brain/awp207
    Journal articles | 2009
    Dr Kate Patterson
    Wang LL; Madigan MC; Chen H; Liu F; Patterson K; Beretov J; O Brien P; Li Y, 2009, 'Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients', Gynecologic Oncology, vol. 114, pp. 265 - 272, http://dx.doi.org/10.1016/j.ygyno.2009.04.031
    Journal articles | 2008
    Dr Kate Patterson
    O Brien P; Davies M; Scurry JP; Smith A; Barton CA; Henderson M; Saunders DN; Gloss B; Patterson K; Clancy JL; Heinzelmann-Schwarz V; Scolyer R; Zeng Y; Williams E; Scurr LL; Defazio A; Quinn DI; Watts CK; Hacker NF; Henshall SM; Sutherland RL, 2008, 'The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro', British Journal of Cancer, vol. 98, pp. 1085 - 1093, http://dx.doi.org/10.1038/sj.bjc.6604281
    Journal articles | 2008
    Dr Kate Patterson
    O'Brien PM; Davies MJ; Scurry JP; Smith AN; Barton CA; Henderson MJ; Saunders DN; Gloss BS; Patterson KI; Clancy JL; Heinzelmann-Schwarz VA; Murali R; Scolyer RA; Zeng Y; Williams ED; Scurr L; DeFazio A; Quinn DI; Watts CKW; Hacker NF; Henshall SM; Sutherland RL, 2008, 'The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (British Journal of Cancer (2008) 98, (1085-1093) DOI: 10.1038/sj.bjc.6604281))', British Journal of Cancer, vol. 98, pp. 1880, http://dx.doi.org/10.1038/sj.bjc.6604419
  • Conference Papers | 2019
    Dr Kate Patterson
    Patterson K; Lilja A; Arrebola M; McGhee J, 2019, 'Molecular Genomics Education Through Gamified Cell Exploration in Virtual Reality', in The 17th International Conference on Virtual-Reality Continuum and its Applications in Industry on - VRCAI '19, ACM Press, Brisbane, Australia, presented at The 17th International Conference on Virtual-Reality Continuum and its Applications in Industry, Brisbane, Australia, 14 November 2019 - 16 November 2019, http://dx.doi.org/10.1145/3359997.3365724
    Conference Papers | 2017
    Dr Kate Patterson
    Patterson K, 2017, 'Genome gazing: A 360° stereoscopic animation for Google cardboard', in Proceedings - IEEE Virtual Reality, pp. 439, http://dx.doi.org/10.1109/VR.2017.7892367
    Conference Abstracts | 2005
    Dr Kate Patterson
    Davies R; Xuereb J; Patterson K; Waley P; Halliday GM; Kril J; Hodges JR, 2005, 'The pathology of semantic dementia', in Neuropathology and Applied Neurobiology, Blackwell Publishing Ltd, Inst Child Hlth, London, ENGLAND, Vol. 31, pp. 220 - 220, presented at 106th Annual Meeting of the British-Neuropathological-Society, Inst Child Hlth, London, ENGLAND, 12 January 2005 - 14 January 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000227597500022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Awards

Grants

Media